EV/EBITDA
0.20
+0.04+25.00%
5 min ago
Summary
- As of March 10, 2025, MRSN EV/EBITDA is 0.20, with a rise of +0.04 (+25.00%) during the most recent trading day.
- Over the past year, MRSN EV/EBITDA has increased by +3.65 (+105.80%).
- MRSN EV/EBITDA is now -80.39% below its all-time high of 1.02.
Performance
MRSN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MRSN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +25.0% | -28.7% | -4.1% |
| 1 m1 month | +433.3% | -415.7% | -26.1% |
| 3 m3 months | +105.3% | -105.0% | -78.5% |
| 6 m6 months | +111.8% | -107.7% | -66.3% |
| ytdytd | +114.7% | -114.9% | -62.8% |
| 1 y1 year | +105.8% | -102.2% | -91.0% |
| 5 y5 years | +102.0% | -104.8% | -92.5% |
MRSN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -31.0% | -0.09 | +322.2% | |
| 3 m | 3-month | 0.29 | -31.0% | -4.25 | +104.7% |
| 6 m | 6-month | 0.29 | -31.0% | -4.25 | +104.7% |
| 1 y | 1-year | 0.29 | -31.0% | -4.25 | +104.7% |
| 3 y | 3-year | 0.29 | -31.0% | -4.98 | +104.0% |
| 5 y | 5-year | 0.29 | -31.0% | -23.15 | +100.9% |
| alltime | all time | 1.02 | -80.4% | -23.15 | +100.9% |
Mersana Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.20(-114.7%) |
| 2024 | -1.36(+72.2%) |
| 2023 | -0.79(-69.8%) |
| 2022 | -2.62(+37.9%) |
| Date | Value |
|---|---|
| 2021 | -1.90(-89.7%) |
| 2020 | -18.38(+139.0%) |
| 2019 | -7.69(+1298.2%) |
| 2018 | -0.55(-94.0%) |
| 2017 | -9.20 |
FAQ
- What is Mersana Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Mersana Therapeutics?
- What is MRSN EV/EBITDA year-to-date change?
- What is Mersana Therapeutics EV/EBITDA year-on-year change?
What is Mersana Therapeutics EV/EBITDA?
The current EV/EBITDA of MRSN is 0.20
What is the all time high EV/EBITDA for Mersana Therapeutics?
Mersana Therapeutics all-time high EV/EBITDA is 1.02
What is MRSN EV/EBITDA year-to-date change?
Mersana Therapeutics EV/EBITDA has changed by +1.56 (+114.71%) since the beginning of the year
What is Mersana Therapeutics EV/EBITDA year-on-year change?
Over the past year, MRSN EV/EBITDA has changed by +3.65 (+105.80%)